Twitter

Reference Hub

Reference Category

Rituximab Monotherapy is Effective For Inhibitor Eradication with Concomitant Porcine Factor VIII Followed by Emicizumab for Bleed Control in Acquired Hemophilia A

In this poster for the 2021 NHF Bleeding Disorders Conference, researchers present the results of a study examining eradication of inhibitor with Rituximab Monotherapy

Author(s):
Ellsworth, Chen, Wang, Key, Ma
Date:
August 1, 2021

Document Type:

Posters
View / Download File
Enter your search criteria to find works by title, author, keyword(s), or date.
National Hemophilia Program Coordinating Center
The NHPCC is funded through the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under the Comprehensive Hemophilia Diagnostic and Treatment Centers’ grant #UC8MC24079. The information and content provided here are those of the NHPCC and should not be construed as the official position or policy of, nor should any endorsements be inferred by, HRSA, HHS, or the U.S. government.
ATHN logo

© 2023 ATHN. ATHN is a 501(c)(3) tax exempt organization.
Privacy Statement    Terms of Use    Reference Hub Submission